Zanden, John Jacob Vander (Dana Point, CA, US)
Terwilliger, Rodney (Buena Park, CA, US)

Plaque It!

11/438027

09/09/2008

05/19/2006

Images are available in PDF form when logged in. To view PDFs, Login  or  Create Account (Free!)

Click for automatic bibliography generation

Allergan, Inc. (Irvine, CA, US)

514/662

424/400, 206/532, 206/534, 206/531, 206/539

B65D83/04; A61K9/00; A61K31/13

206/538-539, 514/662, 424/400, 206/531-532, 206/528, 206/534-5342

2415859	Tablet container and dispenser	January, 1947	Ancker
3099352	Calendar reminder and dispensing device	July, 1963	Aven
3225913	Capsule and tablet pocket carrier	December, 1965	Lee
3568828	MODIFIED SEQUENTIAL ORAL CONTRACEPTIVE	March, 1971	Lerner
3738480	MEDICATION CONTAINER	June, 1973	Chesley
3826222	UNIT-DOSE MEDICATION HANDLING SYSTEM	July, 1974	Romick
3921806	Pill dispenser	November, 1975	Wawracz
RE29705	Rupturable blister pill package with safety backing	July, 1978	Compere
4148273	Medicine management device	April, 1979	Hollingsworth et al.
4473156	Method and apparatus for accurately selecting storing and dispensing pills	September, 1984	Martin
4473884	Electronic medication dispensing system	September, 1984	Behl
4617557	Medication compliance aid for unit dose packaging	October, 1986	Gordon
4706815	Dispensing container for triphasic	November, 1987	Curtis et al.
4883180	Color coded medicine caps and labels for daily dosage	November, 1989	Humphrey et al.
4958736	Package for oral contraceptive tablet	September, 1990	Urheim
D330331	Unit dose drug control package	October, 1992	Hsiao
5288107	Multiple information field label	February, 1994	Johnson et al.
D383668	Portable electronic medication dispenser	September, 1997	Siegel
5747545	Method of preventing NMDA receptor complex-mediated Neuronal damage	May, 1998	Lipton
5752235	Electronic medication monitoring and dispensing method	May, 1998	Kehr et al.
5922773	Glaucoma treatment	July, 1999	Lipton et al.
6047829	Unit dose packaging system (UDPS) having a child resistant locking feature	April, 2000	Johnstone et al.
6169707	Medication storage and reminder device	January, 2001	Newland
6375956	Strip pack	April, 2002	Hermelin et al.
6411567	Drug delivery management system	June, 2002	Niemiec et al.
6471645	Communications system for an implantable device and a drug dispenser	October, 2002	Warkentin et al.
6491211	Child resistant carton and method for using the same	December, 2002	Evans et al.
6564945	Medication assemblage for use in sinusitis treatment regimens	May, 2003	Weinstein et al.
6651816	Antihistamine/decongestant regimens for treating rhinitis	November, 2003	Weinstein
7086532	Titration/compliance pack with increasing doses	August, 2006	Zanden et al.	206/534
20040176381	Methotrexate compliance packaging	September, 2004	Wash

CA2218470	December, 1997
EP0852208	June, 1996			TABLET CONTAINER
WO/1997/003896	February, 1997			TABLET CONTAINER
WO/2003/032891	October, 2002			METHOD OF DISPENSING PHARMACEUTICAL SUBSTANCES

Gehman, Bryon P.

Allergan, Inc.
Voet, Martin
Johnson, Brent A.

The present application is a continuation of U.S. Ser. No. 10/622,170 filed Jul. 16, 2003, now U.S. Pat. No. 7,086,532.

What is claimed is:

1. A titration package for enabling compliance with a regimen of changing dosage of medication over a period of time, the package comprising: a backing having an array of receivers, said array including a plurality of columns and a plurality of rows; a plurality of sets of Memantine tablets, each tablet in a set having a common dose of Memantine and a different dose than a Memantine tablet of a different set, each set being disposed in receivers of one of an adjacent row and an adjacent column; different sets of Memantine tablets are disposed in different rows, each row being indicated as a successive week, each column being indicated as a different day of the week, sets of Memantine tablets having increased doses being disposed in receivers of rows indicated as successive weeks; and indicia disposed adjacent the columns and rows for displaying common days and successive weeks.

2. The package according to claim 1 wherein the sets of tablets have 5 mg, 10 mg, 15 mg, and 20 mg doses of Memantine.

3. A titration package for enabling compliance with a regimen of changing dosage of medication over a period of time, the package comprising: a backing having an array of receivers, said array including a plurality of columns and a plurality of rows; a plurality of sets of tablets, each tablet in a set having a common dose of the medication and a different dose than a tablet of a different set, each set being disposed in receivers of one of an adjacent row and an adjacent column; different sets of tablets are disposed in a different plurality of columns, each plurality of columns being indicated as a successive week, each row being indicated as a different day of the week, sets of tablets having increased doses being disposed in receivers of a plurality of columns indicated as successive weeks; and indicia disposed adjacent the columns and rows for displaying common days and successive weeks.

4. The package according to claim 3 wherein the sets of tablets have 5 mg, 10 mg, 15 mg, and 20 mg doses of Memantine.

5. A titration package for enabling compliance with a regimen of changing dosage of medication over a period of time, the package comprising: a backing having an array of receivers, said array including a plurality of columns and a plurality of rows; a plurality of sets of tablets, each tablet in a set having a common dose of the medication and a different dose than a tablet of a different set, each set being disposed in receivers of a plurality of adjacent rows, different sets of tablets are disposed in a different plurality of rows, each plurality of rows being indicated as a successive week, each column being indicated as a different day of the week, sets of tables having increased doses being disposed in receivers of a plurality of rows indicated as successive weeks; and indicia disposed adjacent the columns and rows for displaying common days and successive weeks.

6. The package according to claim 5 wherein pairs of adjacent rows have differing sets of tablets.

7. The package according to claim 5 wherein the sets of tablets have 5 mg, 10 mg, 15 mg, and 20 mg doses of Memantine.

8. The package according to claim 5 wherein pairs of adjacent columns have differing sets of tablets.

9. The package according to claim 8 wherein each pair of columns is indicated as a successive week and each row is indicated as a different day of the week.

10. The package according to claim 9 wherein sets of tablets having increased doses are disposed in receivers of adjacent pairs of columns.

11. The package according to claim 10 wherein the sets of tablets have 5 mg, 10 mg, 15 mg, and 20 mg doses of Memantine.

The present invention is generally directed to a titration package for enabling compliance with a regimen of changing dosage of medication over a period of time and is more particularly directed to a dosage pack for dosing of oral Memantine for the indication of preventing further nerve cell loss in glaucoma patients.

Glaucoma is characterized by damaged to the optic nerve which is typically accompanied by a decrease in normal vision field. An early sign of possible glaucomatous visual field loss is elevated interocular pressure.

In that regard, glaucoma has typically been treated by medically and/or surgically lowering elevated interocular pressure. Memantine and other compounds suitable for chronic administration should be administered to avoid adverse events associated with the drug, for example, patients prescribed Memantine therapy need to be titrated upwards from 5 mg of Memantine per day to a maintenance dose of either 10 mg or 20 mg per day. Memantine approved for other indications also requires similar titration schedules to avoid drug-related adverse events.

The present invention is directed to a titration package for enabling compliance with a regimen of changing dosage of medication over a period of time and further provides for a method of treating a human patient to reduce damage to retinal ganglion cells associated with glaucoma utilizing the titration package in accordance with the present invention.

SUMMARY OF THE INVENTION

A titration package for enabling compliance with a regimen of changing dosage of medication over a period of time in accordance with the present invention generally includes a backing having an array of receivers with the array including a plurality of columns and a plurality of rows.

A plurality of sets of tablets are provided in the receivers. Each tablet in a set has a common dose of medication and a different dose than a tablet of a different set. Each set of tablets is disposed in receivers of one of an adjacent row and an adjacent column.

Indicia is provided and disposed adjacent the columns and rows for displaying common days and successive weeks. Thus, the package provides for a titration schedule which prevents adverse events as a result of mis-dosing. As a result, the package in accordance with the present invention provides for a safer and accordingly more beneficial method for enabling compliance with the regimen.

More particularly, in one embodiment of the present invention different sets of tablets are disposed in different rows with each row being indicated by a successive week and each column being indicated as a different day of the week. In this embodiment, the sets of tablets having increased doses are disposed in receivers in rows indicated as successive weeks. More specifically, the sets of tablets have 5 mg, 10 mg, 15 mg and 20 mg doses of Memantine.

In an alternative embodiment, different sets of tablets are disposed in different columns, with each column being indicated as a successive week and each row being indicated as a different day of the week.

In yet another embodiment of the present invention, the titration package for enabling compliance with a regimen of changing doses of medication over a period of time includes a backing having an array or receivers with the array including a plurality of columns and a plurality of rows. In this embodiment, a plurality of sets of tablets are provided with each set being disposed in receivers of a plurality of adjacent rows or a plurality of adjacent columns. This plurality may be two and each tablet in a set has a common dose of medication and a different dose than a tablet in a different set.

Preferably, in this embodiment pairs of adjacent rows have differing sets of tablets. This enables the change of dosage over an eight-week period of time from 5 mg to 20 mg doses of Memantine.

Thus, the present invention provides for a method for enabling compliance with a regimen of changing dosage of medication with the method comprising the steps of providing a backing having an array of receivers, with the array including a plurality of columns and a plurality of rows. The method further includes disposing a plurality of sets of tablets and the receivers with each tablet in the set having a common dose of medication and a different dose than a tablet of a different set. Each set is disposed in receivers of one of an adjacent row and an adjacent column. The method finally includes a step of providing indicia adjacent the columns and rows indicating common days and successive weeks.

A concomitant method in accordance with the present invention provides for a method of treating a human patient to reduce damage to retinal ganglion cells associated with glaucoma with the method comprising providing a titration package for enabling compliance with a regimen of changing dosage of medication over a period of time. The package includes the elements hereinabove recited and further the medication comprises Memantine.

BRIEF DESCRIPTION OF THE DRAWINGS

The present invention may be more clearly understood with reference to the following detailed description in conjunction with the appended drawings of which:

FIG. 1 is a representation of a titration package in accordance with the present invention for enabling compliance with a regimen of changing dosage of medication over a four-week period of time;

FIG. 2 is a representation of a titration package similar to that shown in FIG. 1 enabling compliance with a regimen of changing dosage of medication over a period of eight weeks; and

FIG. 3 is a representation similar to the titration package shown in FIG. 2 showing an alternative arrangement of days and successive weeks, as will be hereinafter described.

DETAILED DESCRIPTION

The titration package and method in accordance to the present invention is particularly useful for the dosage of oral medication for infirmed and elderly patients and accordingly the manipulation of tablets enabled by the present invention and tracking of compliance with a titration schedule is a great advantage. In the case of treatment of glaucoma, and the use of a medicament, such as, for example Memantine, the progression of blindness also demands a need for the present invention.

With reference to FIG. 1, there is represented a titration package 10 for enabling compliance with a regimen of changing dosage of medication over a period of time, for example four weeks with the package 10 including a backing 12 which includes an array 18 of receivers holding a plurality of sets 24 , 26 , 28 , 30 of tablets 34 , 36 , 38 , 40 .

The receivers 20 may be conventional, rupturable blisters as, for example, as set forth in U.S. Pat. No. RE 29,705 which is to be incorporated herewith in its entirety for the purpose of describing the type of rupturable receivers suitable for use with the present invention.

The backing 12 may be any suitable plastic or paperboard backing and may be incorporated into protective coverings, not shown, such as, for example, shown in U.S. Pat. No. 6,047,829. This patent is to also be incorporated herewith in its entirety by this specific reference thereto for showing a backing and dispensing package construction suitable for use in the present invention.

With continued reference to FIG. 1, the array 18 of receivers 20 includes a plurality of columns indicated by the arrows 44 and a plurality of rows indicated by the arrows 46 . Indicia 50 , 52 is provided and disposed adjacent the columns 44 and rows 46 , preferably on the backing 12 displays common days and successive weeks.

As shown in FIG. 1, different sets are disposed in different rows 46 as indicated by week 1 , week 2 , week 3 , and week 4 . The number following the indicia “week” indicating successive weeks and the columns 44 indicated as Sunday, Monday, Tuesday, Wednesday, Thursday, Friday, and Saturday indicating different days of the week.

With regard to the treatment of glaucoma, the set 24 includes 5 mg of Memantine, the set 26 includes tablets of 10 mg of Memantine, the set 28 includes tablets of 15 mg of Memantine, and the set 30 includes tablets of 20 mg of Memantine arranged in the rows 46 indicated as week 1 , week 2 , week 3 , and week 4 . In accordance with the present invention, a patient utilizing the package and method of the present invention is titrated from a 5 mg dose to a 20 mg dose of the Memantine.

In use, a patient beginning the regimen may start on any given day of the week, for example, Tuesday and progressively take the tablets by rupturing the receivers 20 along a row until all of the tablets 34 have been dispensed. At that time, the patient begins week 2 of the regimen by taking the tablets 36 disposed in the row 46 indicated by the indicia, week 2 .

Thus, the arrangement and dosages of the tablets therein enables compliance with the regimen of changing the dosage of the medication over the period of time, four weeks as indicated in FIG. 1.

With reference to FIG. 2, there is shown an alternative embodiment, or package, 60 in accordance with the present invention for enabling compliance with a regimen of changing dosage of medication over a period of 8 weeks. In this embodiment, a backing 62 is provided with an array 66 of receivers 68 with the array being arranged in rows indicated by the indicia, “week 1 - 8 ” and columns indicated as “Sun-Sat”.

In this embodiment, different sets 72 , 74 , 76 , 78 of tablets 82 are disposed in adjacent rows as shown in FIG. 2 or an adjacent columns as shown in the embodiment 100 of FIG. 3. Character references have been omitted from FIG. 3 to reduce redundancy in description. It should be clear that the embodiment of 60 and 100 are identical except for the arrangement of columns and rows.

In a method of treating a human patient in accordance with the present invention to reduce damage to retinal ganglion cells associated with glaucoma, the titration packages 60 , 100 enable compliance with a regimen of changing dosage of medication over a period of time as hereinabove described in connection with the package 10 shown in FIG. 1.

The patient beginning on any of the week completes the removal and use of tablets in a corresponding week in adjacent rows or column before proceeding to the next pair of adjacent rows or columns in a manner as described hereinabove in connection with the embodiment 10 shown in FIG. 1.

Although there has been hereinabove described a specific titration/compliance pack in accordance with the present invention for the purpose of illustrating the manner in which the invention may be used to advantage, it should be appreciated that the invention is not limited thereto. That is, the present invention may suitably comprise, consist of, or consist essentially of the recited elements. Further, the invention illustratively disclosed herein suitably may be practiced in the absence of any element which is not specifically disclose herein. Accordingly, any and all modifications, variations or equivalent arrangements which may occur to those skilled in the art, should be considered to be within the scope of the present invention as defined in the appended claims.